Financials in USD. Standardized financial statements.
A compact view of how Avecho Biotechnology Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.24M | $1.29M | $473,551 | $1.21M | $793,600 | $384,627 | $4.24M | $1.25M | $1.15M | $1.59M |
| Revenue Growth? | -4.4% | +173.3% | -60.7% | +52.0% | +106.3% | -90.9% | +238.5% | +8.9% | -27.6% | 0.0% |
| Cost of Revenue? | $486,283 | $460,746 | $517,346 | $336,142 | $285,663 | $143,715 | $214,573 | $553,322 | $93,755 | $330,000 |
| Gross Profit? | $750,991 | $833,177 | -$43,795 | $870,025 | $507,937 | $240,912 | $4.02M | $698,994 | $1.06M | $1.26M |
| Gross Margin? | +60.7% | +64.4% | -9.2% | +72.1% | +64.0% | +62.6% | +95.0% | +55.8% | +91.9% | +79.2% |
| Operating Expenses? | $6.75M | $5.63M | $4.72M | $3.86M | $5.06M | $3.65M | $4.02M | $6.02M | $10.87M | $13.29M |
| Operating Income? | -$6.00M | -$4.80M | -$4.59M | -$3.06M | -$4.55M | -$3.41M | $1.57M | -$5.17M | -$9.06M | -$9.29M |
| EBITDA? | -$5.86M | -$2.92M | -$3.24M | -$2.11M | -$2.98M | -$2.09M | $1.54M | -$4.60M | -$9.04M | -$9.56M |
| Income Before Tax | -$6.41M | -$3.12M | -$3.44M | -$2.34M | -$3.42M | -$2.63M | $849,955 | -$3.99M | -$8.62M | -$17.25M |
| Income Tax Expense | -$2.00M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$109,000 | $7.11M |
| Net Income? | -$4.41M | -$3.12M | -$3.44M | -$2.34M | -$3.42M | -$2.63M | $849,955 | -$3.99M | -$8.54M | -$17.31M |
| EPS? | $0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $0.00 | $-0.00 | $-0.01 | $-0.01 |
| Diluted EPS? | $0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $0.00 | $-0.00 | $-0.01 | $-0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality